Cargando…
COVID-19 and drug-induced liver injury: a problem of plenty or a petty point?
Autores principales: | Boeckmans, Joost, Rodrigues, Robim M., Demuyser, Thomas, Piérard, Denis, Vanhaecke, Tamara, Rogiers, Vera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138655/ https://www.ncbi.nlm.nih.gov/pubmed/32266419 http://dx.doi.org/10.1007/s00204-020-02734-1 |
Ejemplares similares
-
Infections at the nexus of metabolic-associated fatty liver disease
por: Boeckmans, Joost, et al.
Publicado: (2021) -
Oral pathology and the problem of plenty that isn't!
por: Donoghue, Mandana
Publicado: (2020) -
Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery
por: Boeckmans, Joost, et al.
Publicado: (2022) -
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
por: Boeckmans, Joost, et al.
Publicado: (2019) -
Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH
por: Boeckmans, Joost, et al.
Publicado: (2020)